UnknownNot Applicable

Ocular Changes in Vitiligo Patients on Therapy

Egypt100 participantsStarted 2022-03-10

Plain-language summary

Vitiligo patients on systemic and local therapy may have some ocular adverse effects associated with the disease and its therapy.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * vitiligo patients on systemic and local therapy that regularly visit dermatology clinic at banha university. * normal subjects seeking regular ophthalmic examination at ophthalmology clinic at banha university. Exclusion Criteria: * patients with known chronic retinal diseases that may alter OCT-A parameters as age related macular degeneration and diabetic retinopathies. * patients that refuse to participate in this study.

What they're measuring

Percentage of vessel density (VD) in superficial and deep retinal layer.

Timeframe: Immediately after OCT-A for each eye and at one month of follow-up.

Trial details

NCT IDNCT05335746

SponsorBenha University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-09-30

Contact for this trial

Ahmed Abdelshafy, MD

01222328766 ahmad4lg@gmail.com

View on ClinicalTrials.gov More Vitiligo trials